documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
5 rows where docket_id = "FDA-2019-N-5192" sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_date, posted_month, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
document_type 3
agency_id 1
- FDA 5
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2019-N-5192-0014 | FDA | None FDA-2019-N-5192 | Microbiology Devices; Reclassification of Human Immunodeficiency Virus Serological Diagnostic and Supplemental Tests and Human Immunodeficiency Virus Nucleic Acid Diagnostic and Supplemental Tests | Rule | Final Rule | 2022-05-16T04:00:00Z | 2022 | 5 | 2022-05-16T04:00:00Z | 2022-05-16T14:35:27Z | 2022-10461 | 0 | 0 | 090000648507f151 | |
| FDA-2019-N-5192-0003 | FDA | None FDA-2019-N-5192 | Reference 2 - Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies re: Microbiology Devices; Reclassification of Human Immunodeficiency Virus Serological Diagnostic and Supplemental Tests and Human Immunodeficiency Virus Nucleic Acid Diagnostic and Supplemental Tests | Supporting & Related Material | Background Material | 2020-02-21T05:00:00Z | 2020 | 2 | 2020-02-24T00:07:58Z | 0 | 0 | 0900006484399ccf | |||
| FDA-2019-N-5192-0004 | FDA | None FDA-2019-N-5192 | Reference 3 - BPAC-07.18.18-07.19.18-Meeting-Issue-Summary-Reclassification-of-HIV-Point-of-Care-and-Laboratory-based-serological-and-NAT-diagnostic-devices re: Microbiology Devices; Reclassification of Human Immunodeficiency Virus Serological Diagnostic and Supplemental Tests and Human Immunodeficiency Virus Nucleic Acid Diagnostic and Supplemental Tests | Supporting & Related Material | Background Material | 2020-02-21T05:00:00Z | 2020 | 2 | 2020-02-24T00:10:37Z | 0 | 0 | 0900006484399cd0 | |||
| FDA-2019-N-5192-0001 | FDA | None FDA-2019-N-5192 | Microbiology Devices; Reclassification of Human Immunodeficiency Virus Serological Diagnostic and Supplemental Tests and Human Immunodeficiency Virus Nucleic Acid Diagnostic and Supplemental Tests | Proposed Rule | Notice of Proposed Rulemaking (NPRM) | 2020-02-21T05:00:00Z | 2020 | 2 | 2020-02-21T05:00:00Z | 2020-04-22T03:59:59Z | 2020-04-22T01:00:35Z | 2020-03515 | 0 | 0 | 0900006484397dd6 |
| FDA-2019-N-5192-0002 | FDA | None FDA-2019-N-5192 | Reference 1 - Revised Recommendations for HIV Testing of Adults, Adolescents, and Pregnant Women in Health-Care Settings re: Microbiology Devices; Reclassification of Human Immunodeficiency Virus Serological Diagnostic and Supplemental Tests and Human Immunodeficiency Virus Nucleic Acid Diagnostic and Supplemental Tests | Supporting & Related Material | Background Material | 2020-02-21T05:00:00Z | 2020 | 2 | 2020-02-24T00:05:31Z | 0 | 0 | 0900006484399cce |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;